First Financial Corp Abbott Laboratories Transaction History

First Financial Corp

$214 Million
Q4 2024

A detailed history of First Financial Corp transactions in Abbott Laboratories stock. As of the latest transaction made, First Financial Corp holds 16,634 shares of ABT stock, worth $1.94 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares

16,634

Previous 16,439 1.19%

Holding current value

$1.94 Million

Previous $1.87 Million 0.37%

% of portfolio

0.88%

Previous 0.9%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	BUY	$111.93 - $119.39 $21,826 - $23,281	195 Added 1.19%	16,634 $1.88 Million
Q3 2024 Oct 24, 2024	BUY	$100.07 - $118.13 $3,402 - $4,016	34 Added 0.21%	16,439 $1.87 Million
Q2 2024 Jul 11, 2024	SELL	$100.73 - $112.44 $70,913 - $79,157	-704 Reduced 4.11%	16,405 $1.7 Million
Q1 2024 Apr 12, 2024	SELL	$109.52 - $120.96 $473,564 - $523,031	-4,324 Reduced 20.17%	17,109 $1.94 Million
Q4 2023 Jan 16, 2024	BUY	$90.19 - $110.4 $28,590 - $34,996	317 Added 1.5%	21,433 $2.36 Million
Q3 2023 Oct 11, 2023	BUY	$95.53 - $114.62 $354,607 - $425,469	3,712 Added 21.33%	21,116 $2.05 Million
Q2 2023 Jul 14, 2023	SELL	$100.78 - $112.29 $113,881 - $126,887	-1,130 Reduced 6.1%	17,404 $1.9 Million
Q1 2023 Apr 17, 2023	SELL	$96.86 - $114.01 $484 - $570	-5 Reduced 0.03%	18,534 $1.88 Million
Q4 2022 Jan 17, 2023	SELL	$95.06 - $111.52 $190 - $223	-2 Reduced 0.01%	18,539 $0
Q3 2022 Oct 20, 2022	BUY	$96.76 - $112.03 $30,672 - $35,513	317 Added 1.74%	18,541 $1.79 Million
Q2 2022 Jul 15, 2022	BUY	$102.07 - $123.37 $9,084 - $10,979	89 Added 0.49%	18,224 $1.98 Million
Q1 2022 Apr 14, 2022	BUY	$114.02 - $139.04 $39,336 - $47,968	345 Added 1.94%	18,135 $2.15 Million
Q4 2021 Jan 14, 2022	SELL	$115.53 - $141.46 $24,723 - $30,272	-214 Reduced 1.19%	17,790 $2.5 Million
Q3 2021 Oct 18, 2021	BUY	$116.66 - $129.06 $26,481 - $29,296	227 Added 1.28%	18,004 $2.13 Million
Q2 2021 Jul 15, 2021	BUY	$105.79 - $124.53 $58,501 - $68,865	553 Added 3.21%	17,777 $2.06 Million
Q1 2021 Apr 15, 2021	SELL	$108.84 - $128.23 $19,155 - $22,568	-176 Reduced 1.01%	17,224 $2.06 Million
Q4 2020 Jan 15, 2021	SELL	$105.0 - $114.42 $18,060 - $19,680	-172 Reduced 0.98%	17,400 $1.91 Million
Q3 2020 Oct 13, 2020	SELL	$91.64 - $111.29 $18,511 - $22,480	-202 Reduced 1.14%	17,572 $1.91 Million
Q2 2020 Jul 15, 2020	SELL	$76.57 - $98.0 $192,879 - $246,862	-2,519 Reduced 12.41%	17,774 $1.63 Million
Q1 2020 Apr 15, 2020	BUY	$62.82 - $91.86 $439 - $643	7 Added 0.03%	20,293 $1.6 Million
Q4 2019 Jan 15, 2020	SELL	$78.51 - $87.4 $10,991 - $12,236	-140 Reduced 0.69%	20,286 $1.76 Million
Q3 2019 Oct 15, 2019	SELL	$81.84 - $88.74 $85,686 - $92,910	-1,047 Reduced 4.88%	20,426 $1.71 Million
Q2 2019 Jul 15, 2019	SELL	$72.88 - $85.0 $73,171 - $85,340	-1,004 Reduced 4.47%	21,473 $1.81 Million
Q1 2019 Apr 12, 2019	BUY	$66.22 - $80.06 $11,588 - $14,010	175 Added 0.78%	22,477 $1.8 Million
Q4 2018 Jan 15, 2019	SELL	$65.56 - $74.27 $333,438 - $377,737	-5,086 Reduced 18.57%	22,302 $1.61 Million
Q3 2018 Oct 16, 2018	SELL	$60.81 - $73.36 $7,601 - $9,170	-125 Reduced 0.45%	27,388 $2.01 Million
Q2 2018 Jul 12, 2018	SELL	$57.57 - $63.54 $921 - $1,016	-16 Reduced 0.06%	27,513 $1.68 Million
Q1 2018 Apr 17, 2018	BUY	$56.27 - $63.62 $97,966 - $110,762	1,741 Added 6.75%	27,529 $1.65 Million
Q4 2017 Jan 16, 2018	SELL	$53.68 - $57.47 $90,289 - $96,664	-1,682 Reduced 6.12%	25,788 $1.47 Million
Q3 2017 Oct 13, 2017	BUY	$48.06 - $53.64 $1.32 Million - $1.47 Million	27,470	27,470 $1.47 Million

Others Institutions Holding ABT

# of Institutions

3,198

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Financial Corp with notifications on news.

Account

First Financial Corp Abbott Laboratories Transaction History